Quantbot Technologies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Quantbot Technologies’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,900	Closed	-$72K	–	2311
2022 Q1	$72K	Buy	+3,900	New	+$70.2K	0.01%	1116
2021 Q4	–	Sell	-36,076	Closed	-$666K	–	2066
2021 Q3	$666K	Buy	+36,076	New	+$726K	0.05%	504

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantbot Technologies's OCDX Position: Q2 2022 in Review

Quantbot Technologies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 3,900 shares — an estimated $72K sold.

Quantbot Technologies first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $666K in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Quantbot Technologies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 3,900 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $72K.
Quantbot Technologies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
Quantbot Technologies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $666K in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.